Stockreport

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]

Biomerica, Inc.  (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
PDF The $300 rate will apply to claims approved and paid by Medicare with dates of service on or after January 1, 2026. Adults of Medicare age comprise over 20% of US adu [Read more]